Sumit Raybardhan
Impact in
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
-
- Nosocomial Infections in ICU
Papers in
-
- Antibiotic Use and Resistance 11
-
- Antimicrobial Resistance in Staphylococcus 3
- COVID-19 Clinical Research Studies 2
- Co-authors
- Bradley J. Langford (8 shared papers)Valerie Leung (7 shared papers)Nick Daneman (6 shared papers)Miranda So (6 shared papers)Derek R. MacFadden (6 shared papers)Duncan Westwood (3 shared papers)Jean‐Paul Soucy (4 shared papers)Daniel Ricciuto (5 shared papers)
- Journals
- Clinical Microbiology and Infection (4 papers)Clinical Infectious Diseases (2 papers)American Journal of Health-System Pharmacy (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)European Journal of Clinical Microbiology & Infectious Diseases (1 paper)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
Sumit Raybardhan
21 papers receiving 2.3k citations
Sumit Raybardhan's Hit Papers
Peers
Comparison fields: 5 of 114
- Applied Microbiology and Biotechnology 1.0k
- Critical Care and Intensive Care Medicine 217
- Molecular Medicine 245
- Infectious Diseases 697
- Geriatrics and Gerontology 68
Countries citing papers authored by Sumit Raybardhan
This map shows the geographic impact of Sumit Raybardhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumit Raybardhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumit Raybardhan more than expected).
Fields of papers citing papers by Sumit Raybardhan
This network shows the impact of papers produced by Sumit Raybardhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumit Raybardhan. The network helps show where Sumit Raybardhan may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumit Raybardhan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis Hit paper breakdown → | 2020 | 1028 |
| 2 | Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis Hit paper breakdown → | 2021 | 537 |
| 3 | 2015 | 198 | |
| 4 | Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis Hit paper breakdown → | 2022 | 146 |
| 5 | Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis Hit paper breakdown → | 2023 | 101 |
| 6 | 2015 | 65 | |
| 7 | 2021 | 61 | |
| 8 | 2017 | 47 | |
| 9 | 2018 | 35 | |
| 10 | 2015 | 24 | |
| 11 | 2021 | 20 | |
| 12 | 2017 | 19 | |
| 13 | 2005 | 19 | |
| 14 | 2020 | 15 | |
| 15 | 2022 | 13 | |
| 16 | 2015 | 9 | |
| 17 | 2019 | 6 | |
| 18 | 2017 | 5 | |
| 19 | 2009 | 4 | |
| 20 | 2017 | 3 |
About Sumit Raybardhan
Sumit Raybardhan is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Pharmacology, Epidemiology and Clinical Biochemistry, having authored 21 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (11 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Infective Endocarditis Diagnosis and Management (2 papers), Drug-Induced Adverse Reactions (2 papers), COVID-19 Clinical Research Studies (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper) and Patient Satisfaction in Healthcare (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (1.0k citations), Critical Care and Intensive Care Medicine (217 citations), Molecular Medicine (245 citations), Infectious Diseases (697 citations) and Geriatrics and Gerontology (68 citations). Sumit Raybardhan has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include Bradley J. Langford, Valerie Leung, Nick Daneman, Miranda So, Derek R. MacFadden, Duncan Westwood, Jean‐Paul Soucy, Daniel Ricciuto, Anna Chiu and Anthony D. Bai. Their work appears in journals such as Clinical Microbiology and Infection, Clinical Infectious Diseases, American Journal of Health-System Pharmacy, Journal of Antimicrobial Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.